340 related articles for article (PubMed ID: 19255147)
1. Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor.
Beauvais DM; Ell BJ; McWhorter AR; Rapraeger AC
J Exp Med; 2009 Mar; 206(3):691-705. PubMed ID: 19255147
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial-cadherin stimulates syndecan-1-coupled insulin-like growth factor-1 receptor and cross-talk between αVβ3 integrin and vascular endothelial growth factor receptor 2 at the onset of endothelial cell dissemination during angiogenesis.
Rapraeger AC; Ell BJ; Roy M; Li X; Morrison OR; Thomas GM; Beauvais DM
FEBS J; 2013 May; 280(10):2194-206. PubMed ID: 23331867
[TBL] [Abstract][Full Text] [Related]
3. Syndecan-1 couples the insulin-like growth factor-1 receptor to inside-out integrin activation.
Beauvais DM; Rapraeger AC
J Cell Sci; 2010 Nov; 123(Pt 21):3796-807. PubMed ID: 20971705
[TBL] [Abstract][Full Text] [Related]
4. Synstatin: a selective inhibitor of the syndecan-1-coupled IGF1R-αvβ3 integrin complex in tumorigenesis and angiogenesis.
Rapraeger AC
FEBS J; 2013 May; 280(10):2207-15. PubMed ID: 23375101
[TBL] [Abstract][Full Text] [Related]
5. Syndecan-1-Induced ECM Fiber Alignment Requires Integrin αvβ3 and Syndecan-1 Ectodomain and Heparan Sulfate Chains.
Yang N; Friedl A
PLoS One; 2016; 11(2):e0150132. PubMed ID: 26909794
[TBL] [Abstract][Full Text] [Related]
6. The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells.
Beauvais DM; Burbach BJ; Rapraeger AC
J Cell Biol; 2004 Oct; 167(1):171-81. PubMed ID: 15479743
[TBL] [Abstract][Full Text] [Related]
7. CNTO 95, a fully human monoclonal antibody that inhibits alphav integrins, has antitumor and antiangiogenic activity in vivo.
Trikha M; Zhou Z; Nemeth JA; Chen Q; Sharp C; Emmell E; Giles-Komar J; Nakada MT
Int J Cancer; 2004 Jun; 110(3):326-35. PubMed ID: 15095296
[TBL] [Abstract][Full Text] [Related]
8. alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro.
Nisato RE; Tille JC; Jonczyk A; Goodman SL; Pepper MS
Angiogenesis; 2003; 6(2):105-19. PubMed ID: 14739617
[TBL] [Abstract][Full Text] [Related]
9. Functional overlap and cooperativity among alphav and beta1 integrin subfamilies during skin angiogenesis.
Perruzzi CA; de Fougerolles AR; Koteliansky VE; Whelan MC; Westlin WF; Senger DR
J Invest Dermatol; 2003 Jun; 120(6):1100-9. PubMed ID: 12787141
[TBL] [Abstract][Full Text] [Related]
10. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v)beta(3) blockade of endothelial cells.
Yeh CH; Peng HC; Yang RS; Huang TF
Mol Pharmacol; 2001 May; 59(5):1333-42. PubMed ID: 11306719
[TBL] [Abstract][Full Text] [Related]
11. Syndecan-1-mediated cell spreading requires signaling by alphavbeta3 integrins in human breast carcinoma cells.
Beauvais DM; Rapraeger AC
Exp Cell Res; 2003 Jun; 286(2):219-32. PubMed ID: 12749851
[TBL] [Abstract][Full Text] [Related]
12. A selective cyclic integrin antagonist blocks the integrin receptors alphavbeta3 and alphavbeta5 and inhibits retinal pigment epithelium cell attachment, migration and invasion.
Hoffmann S; He S; Jin M; Ehren M; Wiedemann P; Ryan SJ; Hinton DR
BMC Ophthalmol; 2005 Jun; 5():16. PubMed ID: 15987521
[TBL] [Abstract][Full Text] [Related]
13. Alpha(v)beta3 and alpha(v)beta5 integrins bind both the proximal RGD site and non-RGD motifs within noncollagenous (NC1) domain of the alpha3 chain of type IV collagen: implication for the mechanism of endothelia cell adhesion.
Pedchenko V; Zent R; Hudson BG
J Biol Chem; 2004 Jan; 279(4):2772-80. PubMed ID: 14610079
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist.
Kumar CC; Malkowski M; Yin Z; Tanghetti E; Yaremko B; Nechuta T; Varner J; Liu M; Smith EM; Neustadt B; Presta M; Armstrong L
Cancer Res; 2001 Mar; 61(5):2232-8. PubMed ID: 11280792
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the signaling pathway of syndecan-1 by synstatin: A promising anti-integrin inhibitor of angiogenesis and proliferation in HCC in rats.
Metwaly HA; El-Gayar AM; El-Shishtawy MM
Arch Biochem Biophys; 2018 Aug; 652():50-58. PubMed ID: 29928859
[TBL] [Abstract][Full Text] [Related]
16. The CXC-chemokine CXCL4 interacts with integrins implicated in angiogenesis.
Aidoudi S; Bujakowska K; Kieffer N; Bikfalvi A
PLoS One; 2008 Jul; 3(7):e2657. PubMed ID: 18648521
[TBL] [Abstract][Full Text] [Related]
17. Biological and molecular properties of a new alpha(v)beta3/alpha(v)beta5 integrin antagonist.
Belvisi L; Riccioni T; Marcellini M; Vesci L; Chiarucci I; Efrati D; Potenza D; Scolastico C; Manzoni L; Lombardo K; Stasi MA; Orlandi A; Ciucci A; Nico B; Ribatti D; Giannini G; Presta M; Carminati P; Pisano C
Mol Cancer Ther; 2005 Nov; 4(11):1670-80. PubMed ID: 16275988
[TBL] [Abstract][Full Text] [Related]
18. Vascular smooth muscle cell growth-promoting factor/F-spondin inhibits angiogenesis via the blockade of integrin alphavbeta3 on vascular endothelial cells.
Terai Y; Abe M; Miyamoto K; Koike M; Yamasaki M; Ueda M; Ueki M; Sato Y
J Cell Physiol; 2001 Sep; 188(3):394-402. PubMed ID: 11473366
[TBL] [Abstract][Full Text] [Related]
19. Syndecan-1 regulates alphavbeta5 integrin activity in B82L fibroblasts.
McQuade KJ; Beauvais DM; Burbach BJ; Rapraeger AC
J Cell Sci; 2006 Jun; 119(Pt 12):2445-56. PubMed ID: 16720645
[TBL] [Abstract][Full Text] [Related]
20. Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases.
Chute C; Yang X; Meyer K; Yang N; O'Neil K; Kasza I; Eliceiri K; Alexander C; Friedl A
Breast Cancer Res; 2018 Jul; 20(1):66. PubMed ID: 29976229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
